Precision medicine is no longer just a scientific capability, it is a systemic challenge that requires us to work at pace. We recently had the privilege of exploring this shift at the Asia-Pacific Oncology Summit (APOS) in Sydney. The conversation has moved from what...

The shift from scientific capability to clinical reality requires a community that leans in. We recently had the privilege of exploring this at the Oxford Nanopore Technologies (ONT) Sydney User Group Meeting, held ahead of the Pathology Update and APOS 26...

Precision medicine is no longer just a scientific capability; it is a systemic challenge that requires us to work at pace. We recently had the privilege of exploring this at the Cell & Gene Therapy Summit, proudly co-hosted with ARCS Australia and the Drug...

This year’s global Rare Disease Day theme is “More than you can imagine,” and we are deeply grateful to have seen this vision brought to life at the recent GSNV Rare Disease Day event. We were honored to join leading patient advocates and clinicians on a panel chaired...

It was a privilege to attend the launch of Omico’s 10-Year Impact Report at Parliament House, received by Minister Mark Butler, MP. The outcomes are nothing short of extraordinary. As the Minister put it, the distance we’ve travelled in such a short time is...